Skip to Content
Merck
  • Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold.

Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold.

Bioorganic & medicinal chemistry letters (2012-12-25)
Claire-Lise Ciana, Romain Siegrist, Hamed Aissaoui, Léo Marx, Sophie Racine, Solange Meyer, Christoph Binkert, Ruben de Kanter, Christoph Fischli, Sergio Wittlin, Christoph Boss
ABSTRACT

A novel series of anti-malarials, based on a hydroxy-ethyl-amine scaffold, initially identified as peptidomimetic protease inhibitors is described. Combination of the hydroxy-ethyl-amine anti-malarial phramacophore with the known Mannich base pharmacophore of amodiaquine (57) resulted in promising in vivo active novel derivatives.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Hydroxylamine solution, 50 wt. % in H2O
Sigma-Aldrich
Hydroxylamine solution, 50 wt. % in H2O, 99.999%